Jarushka Naidoo/X
Mar 31, 2025, 05:03
Jarushka Naidoo: My ELCC 2025 Top 3 – MARIPOSA, KRYSTAL7 and Deescalation trials
Jarushka Naidoo, Full Professor and Consultant Medical Oncologist at Royal College of Surgeons in Ireland, shared a post on X:
“My ELCC25 Top 3:
1. MARIPOSA: meets OS (HR 0.75), but tox burden limits to a subset of patients? Controversial
2. KRYSTAL7: mPFS 27.7m. Way better than I expected. One to watch
3. Deescalation trials by Benjamin Besse. Let’s be good oncologists, and good citizens
Thanks ESMO.”
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Apr 1, 2025, 14:08
Apr 1, 2025, 12:48
Apr 1, 2025, 12:16
Apr 1, 2025, 12:13
Apr 1, 2025, 12:07